Blog categories

Pfizer Canada invests in the NEOMED Institute

12 June 2018

Pfizer Canada is proud to announce a $1.2 million contribution to the NEOMED Institute.

 

Pfizer Canada’s support of the NEOMED Institute will accelerate the commercialization of new drugs resulting from scientific discoveries at universities.

 

This contribution will also strengthen the ties between private companies, universities and research centres, to better meet the needs of patients, which is a goal of the Quebec Life Sciences Strategy. 

 

About Pfizer Canada

Pfizer Canada Inc. is the Canadian operation of Pfizer Inc., one of the world’s leading biopharmaceutical companies. 

 

About the NEOMED Institute

The NEOMED Institute is a not-for-profit organization whose mission is to enable and accelerate the commercialization of life science discoveries. 

 

Information

neomed.ca

* indicates required
Langue/Language *

* indicates required
Langue/Language *

DESTL Inc. MAGAZINE SUBSCRIPTION

Please complete this form

DESTL Team

Warning
Error
Ok